A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...
A study published earlier this year in the Journal of Neuro-Oncology indicates that sonodynamic therapy (SDT) safely destroys GBM cells while preserving healthy brain tissue. Using a noninvasive ...
UW researchers found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of ...
You might have heard about Trodelvy, a medicine the FDA approved in 2021 and 2023 to treat some types of breast cancer. Trodelvy is for adults with triple-negative breast cancer (TNBC) or hormone ...
A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...
Cancer Treatment Centers of America (CTCA) in metro Atlanta is part of the CTCA Comprehensive Cancer Care Network and is located in historic Newnan, just outside of Atlanta. Specializing in treating ...
Alexander Olawaiye does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer. If you have been diagnosed with NSCLC, your health care provider may test your cancer to see if it has certain genetic ...
Treatments are being switched around; surgeries postponed. Oncologists are meeting new patients via Zoom or swathed in impersonal protective gear. Both the newly diagnosed and those with metastatic ...
Bats get a deadly bad rap — but they could play a lifesaving role in cancer treatment, according to a “fascinating new study” that examines their remarkable immune systems. Despite their long ...
Treating precursor anal cancer lesions can significantly reduce the risk of progression to full blown anal cancer among people living with HIV, according to results of a large, phase 3 study led by ...